Review: taking Vitamin d and Copaxone together


Summary

Drug interactions are reported among people who take Vitamin d and Copaxone together. This review analyzes the effectiveness and drug interactions between Vitamin d and Copaxone. It is created by eHealthMe based on reports of 242 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Vitamin d and Copaxone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vitamin D

Vitamin d has active ingredients of ergocalciferol. It is often used in vitamin supplementation. (latest outcomes from Vitamin d 17,667 users)

Copaxone

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 14,035 users)

On Aug, 29, 2016

242 people who take Vitamin D, Copaxone are studied.


Number of reports submitted per year:

Vitamin d and Copaxone drug interactions.

Drug effectiveness over time:

Vitamin D:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 100.0% - (4 of 4 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Copaxone:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 100.0% - (4 of 4 people)
  • 10+ years: 0.0% - (0 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Vitamin D:
  • female: 53.0% - (7 of 13 people)
  • male: 100.0% - (1 of 1 people)
Copaxone:
  • female: 33.0% - (6 of 18 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Vitamin D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 100.0% - (1 of 1 people)
Copaxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 14.0% - (1 of 7 people)
  • 60+: 33.0% - (1 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • convulsion
  • injection site pain
  • oedema peripheral
  • swollen tongue
  • urticaria
  • alanine aminotransferase increased
  • allergic reactions
  • arthralgia
  • blood alkaline phosphatase increased
  • elevated liver enzymes
1 - 6 months:
  • allergic reactions
  • aphthous stomatitis
  • cardiac arrest
  • chest pain
  • elevated liver enzymes
  • flushing
  • headache
  • hepatitis
  • hepatitis acute
  • injection site oedema
6 - 12 months:
  • anemia
  • bursitis
  • gestational diabetes
  • headache
  • live birth
  • piloerection
1 - 2 years:
  • angioedema
  • cellulitis
  • dermatitis
  • eye swelling
  • hangover
  • mechanical urticaria
  • shingles
  • skin lesion
  • tiredness
  • anemia
2 - 5 years:
  • compulsive hair pulling
  • neck pain
  • numbness and tingling
  • optic neuritis
  • abasia
  • anxiety
  • arthralgia
  • choking
  • confusional state
  • fear
5 - 10 years:
  • rash generalised
  • rash maculo-papular
  • rash pruritic
  • skin haemorrhage
  • dizziness
  • fatigue
  • irregular heartbeat
  • weak pulse
10+ years:
  • anxiety and stress
  • bipolar 2
  • bipolar ii disorder
  • migraine
  • multiple sclerosis
  • tmj disorders
not specified:
  • dizziness
  • fatigue
  • gait disturbance
  • nausea
  • multiple sclerosis relapse
  • fall
  • hypoaesthesia
  • muscular weakness
  • insomnia
  • headache

Most common drug interactions by gender *:

female:
  • nausea
  • dizziness
  • fatigue
  • headache
  • insomnia
  • multiple sclerosis
  • multiple sclerosis relapse
  • back pain
  • gait disturbance
  • muscular weakness
male:
  • fatigue
  • dizziness
  • gait disturbance
  • fall
  • hypoaesthesia
  • asthenia
  • urinary tract infection
  • foot fracture
  • loss of consciousness
  • multiple sclerosis relapse

Most common drug interactions by age *:

0-1:
  • pyloric stenosis
2-9:
  • choking
  • depressed level of consciousness
20-29:
  • drug ineffective
  • gestational diabetes
  • injection site erythema
  • injection site reaction
  • injection site swelling
  • live birth
  • muscle twitching
30-39:
  • loss of consciousness
  • asthenia
  • dizziness
  • fall
  • fatigue
  • foot fracture
  • hypoaesthesia
  • orthostatic hypotension
  • syncope
  • urinary tract infection
40-49:
  • insomnia
  • multiple sclerosis relapse
  • abdominal discomfort
  • fatigue
  • headache
  • muscular weakness
  • abdominal pain
  • adverse event
  • anxiety
  • anxiety and stress
50-59:
  • nausea
  • back pain
  • diarrhoea
  • dizziness
  • gait disturbance
  • multiple sclerosis relapse
  • balance disorder
  • fatigue
  • feeling abnormal
  • malaise
60+:
  • dizziness
  • fall
  • fatigue
  • urinary tract infection
  • asthenia
  • gait disturbance
  • hypoaesthesia
  • foot fracture
  • insomnia
  • loss of consciousness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vitamin d and Copaxone?

Can you answer these questions?

More questions for: Vitamin d, Copaxone

You may be interested in these reviews

More reviews for: Vitamin d, Copaxone

On eHealthMe, Vitamin d (ergocalciferol) is often used to treat vitamin supplementation. Copaxone (glatiramer acetate) is often used to treat multiple sclerosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.